It was found to be upregulated in various cancers, including breast cancer, pancreatic cancer, HCC and EOC [14, 31–33]; furthermore, the high expression of TPT1 was significantly associated with the malignant behaviour of the tumour and the prognosis of the patient. This evidence concerns the gene TPT1 and hepatocellular carcinoma.